Position in NTRA
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$2,558,416
+$1,588,465 QoQ
Shares Held
9,425
+94.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#339
of 844 holders
Holding Since
Mar 2025
3 quarters on record
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Saudi Central Bank holds $41,422,858 across 11 Diagnostics & Research names. NTRA ranks #6 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
26,014 | $13,042,379 | |
| 2 | DHR |
Danaher Corp /De/
|
44,585 | $8,492,550 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
5,560 | $2,927,006 | |
| 4 | A |
Agilent Technologies, Inc.
|
19,782 | $2,627,643 | |
| 5 | WAT |
Waters Corp /De/
|
6,884 | $2,581,775 | |
| 6 | NTRA |
Natera, Inc.
This page
|
9,425 | $2,558,416 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
11,879 | $2,295,260 | |
| 8 | ILMN |
Illumina, Inc.
|
10,435 | $1,834,786 |
All Filings in NTRA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,558,416 | 9,425 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $969,951 | 4,850 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $6,929 | 49 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||